Dual diagnosis treatment for Lake Worth Beach — one team, both diagnoses, together.
A specialist outpatient program for clients in Lake Worth Beach. PHP, IOP, in-house psychiatry, sober-living network, family programming. Same admissions team, 24/7.
Start the conversation Or call directly — (561) 464-4077Local options exist. This is the clinical specialist.
RECO Health's Delray Beach campus is 22 minutes down I-95 from Lake Worth Beach — close enough that clients from Bryant Park, Parrot Cove, and downtown can commute to IOP without leaving the community anchoring their recovery. Every dual diagnosis client is managed by an in-house addiction psychiatrist who prescribes MAT (buprenorphine, naltrexone, acamprosate) and psychotropic medication (SSRIs, mood stabilizers, ADHD medication) on one reconciled medication list, with interactions flagged in real time. Trauma processing (CPT, PE, EMDR) is sequenced after stabilization by therapists dual-trained in substance use and psychiatric care, not outsourced or scheduled independently.
Lake Worth Beach sits 14 miles up A1A from RECO Health’s Delray Beach campus — a 22-minute drive outside of season. For clients from Bryant Park, College Park, Mango Groves, Parrot Cove, and downtown Lake Worth Beach, that proximity is clinically useful: it makes an integrated dual diagnosis program accessible without asking someone to uproot from the neighborhood that anchors their recovery. Many Lake Worth Beach clients commute to IOP a few days a week and use sober-living for the residential and PHP phases, keeping continuity with the same treatment team from stabilization through step-down.
Why sequential treatment fails for co-occurring disorders
The research on this question is not close. Sequential care — “get sober first, then we’ll look at the depression” — produces worse outcomes than integrated care across nearly every metric that matters: retention, relapse, psychiatric hospitalization, and functional recovery. The untreated diagnosis destabilizes the treated one. Untreated major depressive disorder is one of the strongest predictors of early relapse after residential treatment; ongoing substance use, in turn, blocks or blunts SSRI and mood-stabilizer response, which is why so many clients arrive at RECO on antidepressants that “never really worked.”
Integrated treatment — the same clinical team, in the same building, on the same treatment plan, addressing both diagnoses concurrently — has been the endorsed standard of care in SAMHSA and APA guidance for over two decades. The barrier has never been evidence; it has been staffing. Integration requires clinicians dual-credentialed and dual-trained: therapists who can move fluently between motivational interviewing for ambivalence about substance use and cognitive processing therapy for a trauma memory in the same session, and psychiatrists comfortable prescribing buprenorphine and lamotrigine on the same medication list.
The high-prevalence co-occurring diagnoses
Five diagnoses account for the majority of what dual diagnosis clinicians actually see: major depressive disorder, PTSD, generalized anxiety disorder, bipolar II, and adult ADHD. RECO screens all five at intake with validated instruments — the PHQ-9 for depression, PCL-5 for PTSD, GAD-7 for anxiety, MDQ for bipolar spectrum, and ASRS for ADHD — alongside substance-specific measures including the AUDIT, DAST-10, and clinician-administered CIWA-Ar or COWS where withdrawal is active. Screening is not the diagnosis; it drives a structured psychiatric evaluation that produces one.
Each diagnosis has a defined evidence-based pathway inside the program. Depression is addressed with an SSRI or SNRI — sertraline, escitalopram, or venlafaxine are common first-line choices — paired with CBT and behavioral activation, with escalation to augmentation strategies including rTMS and ketamine for the treatment-resistant subset. PTSD is treated with cognitive processing therapy, prolonged exposure, or EMDR once the client’s window of tolerance supports trauma processing. Bipolar disorder is stabilized with lithium, lamotrigine, quetiapine, or aripiprazole, with careful attention to substances that destabilize mood — cocaine and stimulants in particular. ADHD is treated with a non-stimulant like atomoxetine or bupropion where stimulant risk is high, or a monitored stimulant regimen where clinically indicated and recovery is stable.
MAT and psychotropic medication managed by one psychiatrist
Fragmented prescribing across a primary care physician, an outside psychiatrist, and a separate MAT provider is one of the most reliable relapse pathways in the field. Nobody is looking at the whole medication list. Sertraline plus tramadol plus buprenorphine gets prescribed across three offices and interacts across all three. RECO’s model closes that gap: buprenorphine or extended-release naltrexone for opioid use disorder, naltrexone or acamprosate for alcohol use disorder, and the client’s antidepressant, mood stabilizer, antipsychotic, or ADHD medication are all managed by the same in-house addiction psychiatrist, on one medication reconciliation, with interactions and QT-prolongation risks flagged in real time.
That single-prescriber model also matters for induction timing. A client with active opioid use disorder and unstable bipolar II needs buprenorphine induction and mood stabilization sequenced against each other, not scheduled independently by two clinicians who have never spoken. Coordinated dosing is often the difference between a client staying in treatment and leaving against medical advice on day four.
Trauma is often the through-line
For a substantial share of dual diagnosis clients, unprocessed trauma sits upstream of both the substance use and the mood disorder. The addiction is a coping strategy for the trauma; the depression is a downstream consequence of both. Treating the substance use alone, without addressing the trauma, tends to work in the short term and fail in the long term — the client stays sober through structured treatment and relapses six months later when a trigger reactivates the trauma without a coping mechanism in place.
RECO’s protocol screens for trauma at intake with the PCL-5 and a structured clinical interview, stabilizes affect regulation and distress tolerance early using DBT skills and grounding work, and moves into evidence-based trauma processing — cognitive processing therapy, prolonged exposure, or EMDR — once the client’s window of tolerance supports it. The sequencing matters. Trauma processing before stabilization retraumatizes; stabilization without trauma processing leaves the driver of the substance use untouched.
What to expect on the first visit
Admission begins with an ASAM Criteria assessment across all six dimensions — acute intoxication and withdrawal potential, biomedical, emotional/behavioral/cognitive, readiness to change, relapse potential, and recovery environment — administered by an admissions clinician. That assessment determines the appropriate level of care: medically monitored detox, residential, PHP, IOP, or outpatient. If withdrawal is active, CIWA-Ar or COWS scores drive medical management from the first hour, with symptom-triggered dosing of lorazepam for alcohol withdrawal or buprenorphine induction for opioid withdrawal.
The psychiatric evaluation follows within 24 to 72 hours, depending on level of care. The evaluating psychiatrist reviews the screening battery, reconciles current medications, and builds an integrated treatment plan that addresses substance use and psychiatric diagnoses on one document, with one team accountable for both. Weekly treatment team meetings then track progress on both diagnoses simultaneously — a client whose PHQ-9 is not improving does not have their depression written off as “early recovery,” and a client whose cravings are escalating does not have their MAT dose deferred to the next monthly outside appointment.
Insurance and admissions from Lake Worth Beach
RECO Health is in-network with most major commercial carriers including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. Verification of benefits typically takes under an hour and produces a specific out-of-pocket estimate — deductible, coinsurance, and projected length of stay — before admission, so clients from Lake Worth Beach know the financial picture before signing anything. Because dual diagnosis programming bills both psychiatric and substance use benefits concurrently, some policies allow more covered days than a single-diagnosis program would authorize under the same plan.
From Lake Worth Beach, the drive to the Delray campus is 22 minutes down I-95 or A1A outside of season, longer during winter traffic. Admissions can arrange transport for clients without a vehicle or when a family member cannot drive, and same-day intake is routinely available when a bed is open. Clients commuting to IOP from Bryant Park, Parrot Cove, or downtown Lake Worth Beach typically schedule around morning or evening blocks to avoid I-95 rush hour.
Serving residents of: Bryant Park, College Park, Mango Groves, Parrot Cove, downtown Lake Worth.
If it's any of these, we can help.
From Lake Worth Beach callers, most asked.
Does RECO Health accept my insurance for dual diagnosis treatment?
How long does dual diagnosis treatment take?
What happens on the first day at RECO Health?
Can I stay on my antidepressant while starting MAT?
How do I get to RECO Health from Lake Worth Beach?
Can my family be involved in treatment, and what stays confidential?
Other lake worth beach-area communities we serve.
Confidential. No commitment.
Tell us a little and a real human from admissions will call you back. We verify insurance benefits within minutes and tell you honestly whether RECO Health is the right fit — including if we should refer you elsewhere.


